Chang-Wan Son
Direktor/Vorstandsmitglied bei ILSUNG IS CO., LTD.
Profil
Chang-Wan Son is an Independent Director at Ilsung Pharmaceutical Co., Ltd.
He previously served as an Independent Director at Goldenbridge No.
4 Special Purpose Acquisition Co., Ltd.
and as an Associate Professor at YONSEI LAW SCHOOL.
He is a graduate of YONSEI LAW SCHOOL.
Aktive Positionen von Chang-Wan Son
| Unternehmen | Position | Beginn |
|---|---|---|
| ILSUNG IS CO., LTD. | Direktor/Vorstandsmitglied | 20.03.2020 |
Ehemalige bekannte Positionen von Chang-Wan Son
| Unternehmen | Position | Ende |
|---|---|---|
Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd.
 Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd. engages in the mergers and acquisitions. It is formed only to have a purpose of merging and acquiring of growth-oriented industries. The company was founded on September 4, 2015 and is headquartered in Seoul, South Korea. | Direktor/Vorstandsmitglied | 24.03.2017 |
| YONSEI LAW SCHOOL | Corporate Officer/Principal | - |
Ausbildung von Chang-Wan Son
| YONSEI LAW SCHOOL | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ILSUNG IS CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd.
Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Goldenbridge No. 4 Special Purpose Acquisition Co., Ltd. engages in the mergers and acquisitions. It is formed only to have a purpose of merging and acquiring of growth-oriented industries. The company was founded on September 4, 2015 and is headquartered in Seoul, South Korea. | Miscellaneous |
